亚洲国产成人久久77-亚洲国产成人久久99精品-亚洲国产成人久久精品hezyo-亚洲国产成人久久精品动漫-人妖hd-人妖ts在线,一本道高清DVD在线视频,2020亚洲永久精品导航,国产久久视频在线视频观看

當前位置: 首頁 JCRQ3 期刊介紹(非官網)
Faseb Bioadvances

Faseb BioadvancesSCIE

國際簡稱:FASEB BIOADV  參考譯名:生物進展

  • CiteScore分區

    Q1

  • JCR分區

    Q3

基本信息:
ISSN:2573-9832
是否OA:開放
是否預警:否
出版信息:
出版地區:United States
出版商:Wiley
出版語言:English
研究方向:Multiple
評價信息:
影響因子:2.5
CiteScore指數:5.4
SJR指數:0.76
SNIP指數:0.67
發文數據:
Gold OA文章占比:72.34%
研究類文章占比:97.22%
年發文量:36
英文簡介 期刊介紹 CiteScore數據 JCR分區 常見問題

英文簡介Faseb Bioadvances期刊介紹

Faseb Bioadvancements aims to provide a platform for the global bioscience community to publish high-quality research papers. This journal focuses on publishing interdisciplinary biomedical research, regardless of the impact of the research results. As long as the research design and execution are appropriate, it can be considered acceptable. In addition to newly discovered reports, it also welcomes the publication of confirmatory studies and reports based on negative findings.

One of the characteristics of this journal is its emphasis on original research, encouraging scientists to submit their research results, whether it is basic research or translational research. In addition, the magazine also considers publishing opinion articles, opinion fragments, and reports, which cover various aspects of biomedical and biological research, including methodology, education, and history of science. The editorial department of the magazine is composed of a group of well-known senior reviewers who are not only responsible for reviewing articles, but also encourage their colleagues to submit articles to the journal and serve as journal ambassadors. The journal has also launched special topic and small review programs to focus on topics of interest to the scientific community.

期刊簡介Faseb Bioadvances期刊介紹

《Faseb Bioadvances》該刊近一年未被列入預警期刊名單,目前已被權威數據庫SCIE收錄,得到了廣泛的認可。

該期刊投稿重要關注點:

  • 預計審稿時間: 10 Weeks
  • SCIE
  • 非預警

Cite Score數據(2024年最新版)Faseb Bioadvances Cite Score數據

  • CiteScore:5.4
  • SJR:0.764
  • SNIP:0.674
學科類別 分區 排名 百分位
大類:Biochemistry, Genetics and Molecular Biology 小類:Biochemistry, Genetics and Molecular Biology (miscellaneous) Q1 22 / 103

79%

大類:Biochemistry, Genetics and Molecular Biology 小類:Physiology Q2 85 / 193

56%

大類:Biochemistry, Genetics and Molecular Biology 小類:Cancer Research Q3 127 / 230

45%

大類:Biochemistry, Genetics and Molecular Biology 小類:Molecular Medicine Q3 103 / 178

42%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發表論文的年篇均引用次數。CiteScore以Scopus數據庫中收集的引文為基礎,針對的是前四年發表的論文的引文。CiteScore的意義在于,它可以為學術界提供一種新的、更全面、更客觀地評價期刊影響力的方法,而不僅僅是通過影響因子(IF)這一單一指標來評價。

歷年Cite Score趨勢圖

JCR分區Faseb Bioadvances JCR分區

2023-2024 年最新版
按JIF指標學科分區 收錄子集 分區 排名 百分位
學科:BIOCHEMISTRY & MOLECULAR BIOLOGY ESCI Q3 216 / 313

31.2%

學科:CELL BIOLOGY ESCI Q3 148 / 205

28%

按JCI指標學科分區 收錄子集 分區 排名 百分位
學科:BIOCHEMISTRY & MOLECULAR BIOLOGY ESCI Q4 260 / 313

17.09%

學科:CELL BIOLOGY ESCI Q4 166 / 205

19.27%

JCR分區的優勢在于它可以幫助讀者對學術文獻質量進行評估。不同學科的文章引用量可能存在較大的差異,此時單獨依靠影響因子(IF)評價期刊的質量可能是存在一定問題的。因此,JCR將期刊按照學科門類和影響因子分為不同的分區,這樣讀者可以根據自己的研究領域和需求選擇合適的期刊。

歷年影響因子趨勢圖

投稿常見問題